Tempus Launches Prospective “Priority” Research Study and Increases Support for Oncology Research Initiatives Despite Pandemic Challenges
01 juin 2020 10h18 HE
|
Tempus
CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its...
Tempus Launches New Precision Medicine-Driven Tests: Tempus|HRD and Tempus|TO
31 mai 2020 10h30 HE
|
Tempus
CHICAGO, May 31, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch...
Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology
30 mai 2020 10h30 HE
|
Tempus
CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of...
Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones
29 mai 2020 15h55 HE
|
Tempus
CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors
29 oct. 2019 11h00 HE
|
Tempus
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that...
Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities
30 sept. 2019 11h00 HE
|
Tempus
CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a...
Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs
03 sept. 2019 13h00 HE
|
Tempus
CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the...
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
22 août 2019 12h00 HE
|
Tempus
CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the...
Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas
11 juin 2019 08h00 HE
|
Tempus
CHICAGO, June 11, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that...
Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials
03 juin 2019 10h30 HE
|
Tempus
CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a...